Founded in 2012, MindMaze is a global leader in brain technology with a mission to accelerate humanity's ability to recover, learn and adapt.

With over a decade of work at the intersection of neuroscience, biosensing, engineering, mixed reality, and artificial intelligence, the company has enhanced the recovery potential of patients with neurological diseases.

MindMaze combines FDA cleared and CE marked digital therapeutics with best-in-class motion analytics, AI, and cloud technologies to create a universal platform for brain health.

MindMaze Labs, the company's enterprising R&D division, brings ground-breaking neuroscience to everyday life, empowering new human-machine interfaces using neurotechnology.

MindMaze's products include digital neurotherapeutics and teleneurorehabilitation systems, deployed worldwide, improving lives of patients and caregivers with neurological conditions.

The company has a history of pioneering VR-based neuro-restoration technologies and holds numerous patents and certifications, including FDA 510(k) clearances and CE marks.